Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever

Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome

(2013) David Safronetz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

(2013) Yousuke Furuta et al.   ANTIVIRAL RESEARCH

Lethal Crimean-Congo Hemorrhagic Fever Virus Infection in Interferon α/β Receptor Knockout Mice Is Associated With High Viral Loads, Proinflammatory Responses, and Coagulopathy

(2013) Marko Zivcec et al.   JOURNAL OF INFECTIOUS DISEASES

T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro

(2013) T. Baranovich et al.   JOURNAL OF VIROLOGY

The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase

(2013) Zhinan Jin et al.   PLoS One

In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant

(2011) Ilenia Delogu et al.   ANTIVIRAL RESEARCH

Ribavirin for patients with Crimean–Congo haemorrhagic fever: a systematic review and meta-analysis

(2011) Sibel Ascioglu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Hazara virus infection is lethal for adult type I interferon receptor-knockout mice and may act as a surrogate for infection with the human-pathogenic Crimean-Congo hemorrhagic fever virus

(2011) S. D. Dowall et al.   JOURNAL OF GENERAL VIROLOGY

Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions

(2011) Megan J. Brooks et al.   JOURNAL OF MEDICAL VIROLOGY

Mechanism of Inhibition of Enveloped Virus Membrane Fusion by the Antiviral Drug Arbidol

(2011) Elodie Teissier et al.   PLoS One

Re-Evaluation of 400 Crimean-Congo Hemorrhagic Fever Cases in an Endemic Area: Is Ribavirin Treatment Suitable?

(2011) Fazilet Duygu et al.   VECTOR-BORNE AND ZOONOTIC DISEASES

Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever

(2011) Michelle Mendenhall et al.   PLoS Neglected Tropical Diseases

Interacting Roles of Immune Mechanisms and Viral Load in the Pathogenesis of Crimean-Congo Hemorrhagic Fever

(2010) A. Saksida et al.   Clinical and Vaccine Immunology

Early serodiagnosis of acute human Crimean-Congo hemorrhagic fever virus infections by novel capture assays

(2010) Petra Emmerich et al.   JOURNAL OF CLINICAL VIROLOGY

Complete sequence and phylogenetic characterisation of Crimean–Congo hemorrhagic fever virus from Afghanistan

(2010) Stephan Ölschläger et al.   JOURNAL OF CLINICAL VIROLOGY

Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice

(2010) S. Bereczky et al.   JOURNAL OF GENERAL VIROLOGY

Pathogenesis and Immune Response of Crimean-Congo Hemorrhagic Fever Virus in a STAT-1 Knockout Mouse Model

(2010) D. A. Bente et al.   JOURNAL OF VIROLOGY

Synthesis and biological activity of water-soluble polymer complexes of arbidol

(2010) M. Yu. Eropkin et al.   PHARMACEUTICAL CHEMISTRY JOURNAL

Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research

(2010) Carol Kilkenny et al.   PLOS BIOLOGY

Efficacy of arbidol on lethal hantaan virus infections in suckling mice and in vitro

(2009) Hai-ying Deng et al.   ACTA PHARMACOLOGICA SINICA

Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models

(2009) Brian B. Gowen et al.   ANTIVIRAL RESEARCH

Antiviral activity of Arbidol against Coxsackie virus B5 in vitro and in vivo

(2009) Qiong Zhong et al.   ARCHIVES OF VIROLOGY

Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells

(2009) D. F. Smee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: A quasi-experimental study from Turkey

(2009) Nazif Elaldi et al.   JOURNAL OF INFECTION

T-705 (favipiravir) activity against lethal H5N1 influenza A viruses

(2009) M. Kiso et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol

(2008) Irina A. Leneva et al.   ANTIVIRAL RESEARCH

Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion

(2008) Y. Boriskin et al.   CURRENT MEDICINAL CHEMISTRY

Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin

(2008) Brian B. Gowen et al.   PLoS One